loadpatents
name:-0.025444984436035
name:-0.014507055282593
name:-0.0007929801940918
BIALER; Meir Patent Filings

BIALER; Meir

Patent Applications and Registrations

Patent applications and USPTO patent grants for BIALER; Meir.The latest application filed is for "anticonvulsant carbamate derivatives".

Company Profile
0.17.23
  • BIALER; Meir - Jerusalem IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anticonvulsant Carbamate Derivatives
App 20180339963 - BIALER; Meir ;   et al.
2018-11-29
Compositions And Methods Of Treatment Of Status Epilepticus
App 20150038588 - Bialer; Meir ;   et al.
2015-02-05
Acyl-urea derivatives and uses thereof
Grant 8,846,903 - Bialer , et al. September 30, 2
2014-09-30
Amide derivatives of valproic acid and uses thereof
Grant 8,829,242 - Bialer , et al. September 9, 2
2014-09-09
Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof
Grant 8,518,979 - Bialer , et al. August 27, 2
2013-08-27
Compounds useful for treating bipolar disorders
Grant 8,399,708 - Bialer , et al. March 19, 2
2013-03-19
Sulfanylamide Derivatives, Uses Thereof And Compositions Comprising Them
App 20120264827 - Bialer; Meir ;   et al.
2012-10-18
Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
Grant 8,288,442 - Shirvan , et al. October 16, 2
2012-10-16
Amide Derivatives Of Valproic Acid And Uses Thereof
App 20120184623 - Bialer; Meir ;   et al.
2012-07-19
Acyl-urea Derivatives And Uses Thereof
App 20100280124 - Bialer; Meir ;   et al.
2010-11-04
Compounds Useful For Treating Neurological Disorders
App 20100160443 - Bialer; Meir ;   et al.
2010-06-24
Alpha-halo- And Alpha-alkyl-cyclopropylcarboxy Compounds And Uses Thereof
App 20100152254 - Bialer; Meir ;   et al.
2010-06-17
Compounds Useful For Treating Bipolar Disorders
App 20100056827 - Bialer; Meir ;   et al.
2010-03-04
Use Of 2,2,3,3, Tetramethylcyclopropane Carboxylic Acid Derivatives For Treating Psychiatric Disorders
App 20100048721 - BIALER; Meir ;   et al.
2010-02-25
Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
App 20090281045 - Shirvan; Mitchell ;   et al.
2009-11-12
Compounds Useful For Treating Neurological Disorders
App 20090182048 - BIALER; Meir ;   et al.
2009-07-16
Compounds Useful For Treating Neurological Disorders
App 20080139651 - BIALER; Meir ;   et al.
2008-06-12
Compounds Useful For Treating Neurological Disorders
App 20080081839 - Bialer; Meir ;   et al.
2008-04-03
Amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid
Grant 7,232,929 - Bialer , et al. June 19, 2
2007-06-19
Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
App 20070043122 - Bialer; Meir ;   et al.
2007-02-22
Amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid
App 20060148861 - Bialer; Meir ;   et al.
2006-07-06
Compounds useful for treating neurological disorders
App 20060004098 - Bialer; Meir ;   et al.
2006-01-05
Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them
Grant 6,969,732 - Bialer , et al. November 29, 2
2005-11-29
Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epiletic, neurological, and CNS activity, and method for their preparation
Grant 6,960,687 - Bialer , et al. November 1, 2
2005-11-01
Valproyltaurinamide derivatives as anticonvulsant amd CNS active agents
Grant 6,958,416 - Bialer , et al. October 25, 2
2005-10-25
Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epiletic, neurological, and cns activity, and method for their preparation
App 20050131069 - Bialer, Meir ;   et al.
2005-06-16
Valproyltaurinamide derivatives as anticonvulsant amd cns active agents
App 20040242695 - Bialer, Meir ;   et al.
2004-12-02
Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment of prevention of pain and/or headache disorders
App 20040204495 - Shirvan, Mitchell ;   et al.
2004-10-14
Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
App 20030212142 - Shirvan, Mitchell ;   et al.
2003-11-13
Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them
App 20030212131 - Bialer, Meir ;   et al.
2003-11-13
Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them
Grant 6,630,602 - Bialer , et al. October 7, 2
2003-10-07
Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
Grant 6,555,585 - Shirvan , et al. April 29, 2
2003-04-29
Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
App 20020103237 - Shirvan, Mitchell ;   et al.
2002-08-01
Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
App 20020052418 - Shirvan, Mitchell ;   et al.
2002-05-02
Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
Grant 5,585,358 - Bialer , et al. December 17, 1
1996-12-17
Novel controlled release dosage form of valproic acid
Grant 4,913,906 - Friedman , et al. April 3, 1
1990-04-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed